Yang, Chenyi <br/><br/>
CDK4/6 Inhibitor PD 0332991 Sensitizes Acute Myeloid Leukemia to Cytarabine-Mediated Cytotoxicity.  [electronic resource] 

 -  Cancer research  May 2015 
 - 1838-45 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, N.I.H., Extramural 
<br/><br/><label>ISSN: </label>1538-7445 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-14-2486  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Cell Line<br/>Cyclin-Dependent Kinase 4--antagonists & inhibitors<br/>Cyclin-Dependent Kinase 6--antagonists & inhibitors<br/>Cytarabine--pharmacology<br/>DNA Damage--drug effects<br/>DNA Replication--drug effects<br/>HEK293 Cells<br/>HL-60 Cells<br/>Humans<br/>Leukemia, Myeloid, Acute--drug therapy<br/>Mice, Inbred NOD<br/>Mice, SCID<br/>Phosphorylation--drug effects<br/>Piperazines--pharmacology<br/>Protein Kinase Inhibitors--pharmacology<br/>Proto-Oncogene Proteins c-pim-1--genetics<br/>Pyridines--pharmacology<br/>S Phase--drug effects<br/>Transcription, Genetic--drug effects<br/>Tumor Cells, Cultured<br/>Xenograft Model Antitumor Assays